Effects on Intraocular Pressure and Side Effects of 0.005% Latanoprost Applied Once Daily, Evening or Morning: A Comparison with Timolol

Ophthalmology

Volumn 102, Issue 12, 1995, Pages 1743-1752

  Alm, Albert ^a   Stjernschantz, Johan ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Department of Biology   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

LATANOPROST; TIMOLOL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONJUNCTIVA DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA EROSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; EYE COLOR; FEMALE; HUMAN; HYPEREMIA; HYPERPIGMENTATION; INTRAOCULAR HYPERTENSION; KERATOPATHY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION; TREATMENT PLANNING;

EID: 0029588603     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(95)30798-1     Document Type: Article

References (24)

1. Phenyl substituted prostaglandin analogs for glaucoma treatment
2. Phenylsubstituted prostaglandins: potent and selective antiglaucoma agents
3. PhXA34, a new potent ocular hypotensive drug. A study on dose-response relationship and on aqueous humor dynamics in healthy volunteers
4. 2αanalogue, after topical application in normal and ocular hypertensive human eyes
5. 2α-isopropyl ester analogues for glaucoma treatment
6. Intraocular pressure-reducing effect of PhXA41 in patients with increased eye pressure: a one-month study
7. Interaction of PhXA41, a new prostaglandin analogue, with pilocarpine. A study on patients with elevated intraocular pressure
8. Ocular hypotensive effect of PhXA41 in patients with ocular hypertension or primary open-angle glaucoma
9. Intraocular pressure-reducing effect of PhXA41 in ocular hypertension: comparison of dose regimens
10. 2αanalogue (PhXA41). An in-hospital, placebo-controlled study
11. 2αanalog, on aqueous humor dynamics in human eyes
12. Latanoprost administered once daily causes a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol
13. 2α
14. 2αincreases uveoscleral outflow in the cynomolgus monkey
15. 2α-1-isopropylester in the cynomolgus monkey
16. 2αanalogue. Effect on intraocular pressure in patients with ocular hypertension
17. 2α-isopropylester eye drops. Effects in normal human eyes
18. Intraocular pressure reduction with PhXA34, a new prostaglandin analogue, in patients with ocular hypertension
19. 2α-isopropyl ester analogues for glaucoma treatment
20. The ocular effects of eicosanoids and other autacoids: Historic background and the need for a broader perspective
21. Mediation of the ocular response to injury and irritation: Peptides versus prostaglandins
22. Prostanoid-induced blood-aqueous barrier breakdown in rabbits involves the EP2 receptor subtype
23. Phenyl substituted prostaglandin analogs for glaucoma treatment
24. Long-term experience with timolol ophthalmic solution in patients with open-angle glaucoma